Article PDF
Use our pre-submission checklist
Avoid common mistakes on your manuscript.
Acknowledgment
This study was supported by the Pritzker School of Medicine Summer Research Program and The University of Chicago Department of Surgery.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
There are no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mojtahed, S.A., Boyer, N.R., Rao, S.A. et al. ASO Visual Abstract: Cost-Effectiveness Analysis of Adjuvant Therapy for BRAF-Mutant Resected Stage 3 Melanoma in Medicare Patients. Ann Surg Oncol 28 (Suppl 3), 576 (2021). https://doi.org/10.1245/s10434-021-10345-y
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-10345-y